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Bone marrow derived cells engraft to the uterine endometrium and contribute to endometriosis. The mechanism by which these cells
are mobilized and directed to the endometrium has not been previously characterized. We demonstrate that human endometrial
stromal cells (hESCs) produce the chemokine CXCL12 and that bone marrow cells (BMCs) express the CXCL12 receptor, CXCR4.
Treatment with physiological levels of estradiol (E2) induced both CXCL12 and CXCR4 expression in hESCs and BMCs, respectively.
BMCs migrated towards hESCs conditioned media; a CXCR4 antagonist blocked migration indicating that CXCL12 acting through its
receptor, CXCR4, is necessary for chemoattraction of BM cells to human endometrial cells. E2 increased both CXCL12 expression in
endometrial cells and CXCR4 expression in BM cells, further enhancing chemoattraction. E2 induced CXCL12/CXCR4 expression in
endometrium and BM, respectively, drives migration of stem cells to the endometrium. The E2-CXCL12/CXCR4 signaling pathwaymay
be useful in determining treatments for endometrial disorders, andmay be antagonized to block stem cell migration to endometriosis.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).Abbreviations: hESCs, human endometrial stromal cells; BMCs,
bone marrow cells; CXCR4, chemokine receptor type 4; E2,
estradiol; CXCL12 or SDF-1α, stromal derived factor; BM, bone
marrow; HSCs, hematopoietic stem cells; ESCs, endometrial stromal
cells; EPCs, endothelial progenitor cells; MSCs, mesenchymal
stromal cells; mBMCs, mouse bone marrow cells; ER, estrogen
receptor.
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CXCR4 belongs to the CXC family of chemokine receptors.
Interaction of CXCR4 with its ligand, stromal derived factor
(SDF-1α, CXCL12) plays a key role in the mobilization and
homing of stem cells (Hopman and DiPersio, 2014). CXCR4,
expressed on the surface of stem cells, serves as a target for
modulating migration (Lai et al., 2014). CXCL12 is produced
by the stromal cells and endothelial cells of many organs
including bone marrow (BM), endometrium, skeletal muscle,his is an open access article under the CC BY license
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um, CXCL12 is expressed by stromal cells. Estradiol (E2)
stimulates CXCL12 production from endometrial stromal cells
(ESCs) (Ruiz et al., 2010; Tsutsumi et al., 2011) suggesting a
role in stem cell recruitment to the uterus.
BM-derived cells including hematopoietic stem cells
(HSCs), mesenchymal stromal cells (MSCs), and endothelial
progenitor cells (EPCs), significantly contribute to peripheral
tissue repair and angiogenesis (Beauséjour, 2007). Therefore,
factors influencing BM-derived cell migration and function are
likely to have a broad impact. Overexpression of CXCR4 in stem
cells (by cytokine induction or gene transfection) enhances
MSCs homing in vivo to bone marrow as well as migration in
vitro towards CXCL12 (Shi et al., 2007; Liu et al., 2013a;
Marquez-Curtis et al., 2013; Hu et al., 2013). Recently it has
been demonstrated that estrogen receptor (ER) is expressed
in EPCs in vivo and in vitro (Baruscotti et al., 2010). EPCs
proliferation is induced during the menstrual phase and the
proliferation can be affected by estrogen through ERα
activation (Foresta et al., 2010). These studies suggested the
potential regulation of stem cells by sex steroids. Previous
studies from our laboratory showed that BM-derived stem cells
can engraft in themurine endometrium (Du and Taylor, 2007).
We have shown that ischemia–reperfusion injury, toxicant
exposure, and medications can alter the migration of BM-
derived stem cells to the uterus, however the molecular
mechanism responsible for the recruitment and engraftment
of these cells is unknown (Zhou et al., 2011; Sakr et al., 2014;
Lapidot, 2001). Here we report the effects of female sex
hormones estradiol and progesterone on CXCR4 and CXCL12
expression, and the role of this chemokine and its receptor in
migration of BMCs towards hESCs.
Material and methods
Cell culture
Mouse bone marrow cells (mBMCs) were prepared from
8–10 weeks old female C57 BL/6 mice (Charles River
Laboratories, Wilmington, USA) by flushing bone marrow
from the tibia and femur, and filtering the marrow through
sterile 70-μmnylonmesh. The filteredmBMCs were grown at a
density of 2.5 × 106 cells/ml in DMEM/F-12 medium supple-
mented with 15% fetal bovine serum, containing penicillin
(100 μg/ml) and streptomycin (100 μg/ml) (GIBCO-BRL, Rock-
ville, USA). After 48 h the cells were gently washed with PBS
and fresh medium added; the medium was subsequently
changed for every 3–4 days until two weeks when the cells
were used for experiments described below. Mouse uterine
cells (mUCs) were prepared from 6–8 weeks old female C57
BL/6 mice by enzymatic digestion of the uterus in 0.125% type
IA collagenase (Sigma, USA) for 1 h at 37 °C, and then filtered
through a 70-μm filter. Human endometrial stromal cells
(hESCs) were obtained from human endometria in the
proliferative phase as described by Ryan et al. (1994).
Both mUCs and hESCs were cultured in DMEM/F12 medium
supplemented with 10% FBS and penicillin/streptomycin
(100 μg/ml) for one week. The cells were then washed with
PBS, trypsinized, plated and cultured for an additional 48 h
before carry out the experiments. Experiments used to
obtain the mouse and human cells were conducted underapproved Yale Institutional Animal Care and Use Committee
and Human Investigations Committee protocols, respectively.
ABC-immunocytochemistry (ICC) and fluorescent ICC
Cells grown (80% confluent) on glass microscope slides were
fixed with freshly prepared 4% formaldehyde for 10 min and
rinsed three times for 5 min each with PBS. The cells were
blocked with 4% BSA in PBS for 30 min and incubated with the
primary antibody (diluted in 1% BSA in PBS) in a humidified
chamber overnight at 4 °C. For ABC-ICC, the cells were in-
cubated with the secondary antibody in 1% BSA for 30 min at
room temperature. The ABC staining and 3, 3′diaminobenzidine
(DAB) kits (Vector Laboratories, USA) were used to visualize the
immunocytochemical reaction under lightmicroscope (Olympus
BX41). For fluorescence-ICC, the cells were incubated with the
secondary antibody in the dark for 30 min at room temperature
and 4′, 6-diamidino-2-phenylindole (DAPI) (Vector laborato-
ries, UK) was added on to the cells. The slides were examined
under inverted fluorescence microscope (Axiovert 200 M,
Zeiss Company, Germany).
Flow cytometry
After two weeks of culture, mBMCs were analyzed for
mesenchymal stromal cells (MSCs), and endothelial progen-
itor cells (EPCs) by flow cytometry. The cells were incubated
with the fluorescent-labeled antibodies against CD90,
CD105, CD34, Flk-1 (BioLegend, San Diego, USA) and CD31
(eBiosciences, USA), or with isotype-matched irrelevant
antibody (1 μg for 106 cells) for 30 min on ice in dark. The
cells were then washed with flow cytometry staining buffer
3 times for 5 min at 3,000 rpm and the cell pellet was
resuspended in 1 ml ice cold staining buffer for cell sorting.
Flow acquisition was performed on LSRII Fortessa, LSRII, or
FACSCalibur analyzers (BD Biosciences), and data were
analyzed using Diva software (BD Biosciences, USA).
Detection of CXCL12 by ELISA
CXCL12α was assayed from the supernatants of cell cultures
using ELISA kit (R & D Systems, USA) according to the
manufacturer's instructions. mBMC, hESCs and mUC were
cultured in DMEM/F12 supplemented with 10% FBS and 1%
penicillin and streptomycin in a 6-well plate (1 × 105 cells/
well). The supernatants were collected from 48 h old cell
cultures. For steroid treatment, the 48 h old mBMC and
hESCs cells were serum starved overnight and treated for
24 h with E2 or progesterone (P4) (Sigma, USA) at concen-
trations of 1 × 10−8, 1 × 10−7, 1 × 10−6 M. The supernatants
were then collected.
Migration assay
Themigration assay for mBMC and hESC cells was carried out
using 8-μm pore size polycarbonate membrane (Millipore,
USA). The serum free conditioned medium (600 μl) collect-
ed from 48 h old cultures from both cell types was added
into the lower chamber and 200 μl of cells (5 × 104 cells)
was placed into the upper insert. The cells in the upper
16 X. Wang et al.insert were serum starved overnight and treated with either
E2 for 24 h at 1 × 10−7 M, or AMD3100 antagonist of CXCR4
for 30 min before the migration assay. After 16 h in a
humidified CO2 incubator at 37 °C, the non-migrating cells
were scraped with a cotton swab from the top of the
membrane. The cells migrating across the membrane were
fixed, stained, and counted. Results are reported as chemo-
tactic index (CI), defined as the number of cells migrating in
response to the conditioned supernatants divided by number
of cells that responded to the serum-free DMEM/F12 medium.
Ethanol was used as a vehicle control to exclude the
nonspecific effects on CXCR4.Detection of CXCR4 by Western blot
Protein extracts (25 to 30 μg) from different cells, as well as
treated mBMCs, were subjected to SDS-PAGE and immuno-
blotting using standard methods. Anti-CXCR4 and anti-α-
tubulin antibodies used were from Santa Cruz Biotechnology
(Dallas, USA) while secondary antibody conjugated with
horseradish peroxidase was obtained from Cell Signaling
(Beverly, Massachusetts). The CXCR4 protein band densities
were quantified using Quantity One software from BioRad
and relative band density was calculated as a ratio of
sample to α-tubulin.Quantitative real-time RTPCR
RNA was isolated using TRIzol (Invitrogen, Carlsbad, Cali-
fornia) and purified on RNeasy minicolumns (QIAGEN,
Valencia California), with on-column deoxyribonuclease
digestion, as per the manufacturers' instructions.
First-strand cDNA was reverse transcribed using iScript
cDNA Synthesis Kit while iQ SYBR Green Supermix (Bio-Rad,
Hercules, USA) based assays were performed for mCXCR4,
mCXCL12 and α-tubulin for qRT-PCR analysis. The CXCR4
primers were as follows: forward
5′-TTTCAGATGCTTGACGTTGG-3′; and reverse
5′-GCGCTCTGCATCAGTGAC-3′; the CXCL12 primers were,
forward 5′-ACTCACACTGATCGGTTCCA-3′ and reverse
5′-AGGTGCAGGTAGCAGTGACC-3′ and the primers for
α-tubulin were, forward, 5′-ATGGAGGGGAATACAGCCC-3′
and reverse, 5′-TTCTTTGCAGCTCCTTCGTT-3′. For each
experimental sample, a control without reverse transcrip-
tase was run to verify that the amplification product arose
from cDNA and not from genomic DNA. The relative
expression levels normalized to α-tubulin, were determined
using the comparative CT method (also known as the 2ΔΔCT
method) (Applied Biosystems, 1997; Barr and Manning,
1999).Statistics
Results are presented as themean ± S.D. Statistical significance
was determined using one-way ANOVA with the Newman–Keuls
multiple comparisons test. All statistical analyses were carried
out using Graph Pad Prism 4.00 for Macintosh (Graph-Pad
Software for Science Inc., San Diego, CA, USA).Results
Characterization of mBMC
The CXCR4 and CXCL12 genes are remarkably conserved
across diverse species. The human and murine CXCL12
differs by one amino acid and is cross reactive (Lapidot,
2001), providing us with an opportunity to conduct the study
of murine CXCR4 with human CXCL12 signaling. The mBMCs
were cultured for two weeks, washed with PBS, and
trypsinized. The cell pellet was resuspended in FACS staining
buffer and incubated with fluorescent labeled antibodies
against CD90, CD105, CD34, CD31 and Flk-1. The cells were
then and analyzed by FACS. As shown in Fig. 1A, 25.6% of
mBMCs expressed CD90 while CD105 (Fig. 1B), CD34
(Fig. 1C), CD31 (Fig. 1D) and Flk-1 (Fig. 1E) were expressed
on 20.7%, 67.8%, 60.5% and 68.5% of mBMCs respectively.
CD90+ and CD105+ were considered MSC-specific surface
markers while CD34+, CD31+, and Flk-1+ represented the
EPC.Expression of CXCR4 and CXCL12 in mBMC, mUC
and hESCs
Cell lysates were prepared from 48 h old cells and 25 μg of
protein from each cell type was subjected to SDS-PAGE
followed by immunoblotting. As shown in Fig. 2A mBMCs had
the highest CXCR4 expression among the three cell types
while lowest expression was seen in hESCs. The differential
expression of CXCR4 protein levels among these cell types
was correlated with mRNA levels confirmed by qRT-PCR. The
density of specific bands was quantified using Quantity One
software. The relative band density was calculated as a ratio
of sample to ɑ-tubulin (data not shown). The CXCL12α was
measured from the conditioned medium collected from the
48 h old cells using ELISA kit. As shown in Fig. 2B, CXCL12
was predominantly expressed in mBMCs; however hESCs also
expressed CXCL12 at high level while mUCs showed very low
level, CXCL12 expression.
We localized the expression of CXCR4 in mBMCs with
fluorescent ICC. As shown in Fig. 3, the CXCR4 is expressed
intracellularly in 37.5% of mBMCs. Fig. 3A shows CD45
expression on mBMCs while 3B shows CXCR4 expression; 3C
shows DAPI staining for nuclei and 3D shows the merge of
CD45 and CXCR4 expression. CXCR4 expression is predomi-
nantly seen in the CD45 negative cells.Migration of mBMC and hESCs towards chemotactic
activity of conditioned medium
A migration assay was carried out to determine the
chemotactic activity of CXCL12, using the conditioned
media. We detected the migratory capacity of mBMCs
towards hESC supernatant and hESCs towards mBMC super-
natant. As shown in Fig. 4, hESC supernatant significantly
induced the mBMC migration. Pretreatment of mBMCs with
the CXCR4 antagonist AMD3100 blocked the mBMC migration
in a dose-dependent manner, and 100 μg/ml AMD3100
completely abolished the mBMC migration.
Figure 1 Immunophenotypic characterization of mBMCs by FACS. Primary mBMCs were incubated with fluorescent-labeled CD90,
CD105, CD34, CD31, and Flk-1 antibodies or with isotype-matched irrelevant antibody for FACS analysis. Experiments were performed
3 times with different samples and each time in duplicate. Results (% of cells) presented are the average of triplicates.
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Figure 2 Western blot analysis of CXCR4 and quantification of
CXCL12 by ELISA. (A) The CXCR4 protein (25 μg) from mBMC, mUC
or hESCs was subjected to 10%-SDS-PAGE and immunoblotted
against anti-CXCR4 antibody. (B) The expression levels of CXCL12
quantified by ELISA from the supernatants of 48 h old mBMCs,
hESCs and mUCs. The graph presents the mean of three separate
experiments; error bars represent the ±S.D. * denotes a statisti-
cally significant difference (p b 0.05) vs mBMCs and # denotes a
statistically significant difference (p b 0.02) vs hESCs.
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CXCL12 in mBMC and hESCs
qPCR analysis demonstrated that E2 caused a significant
increase in mRNA expression levels of CXCR4 in mBMCs in a
dose dependent manner at 6 h but at 24 h only physiological
levels of E2 (10−7 M) continued to drive CXCR4 expression in
mBMCs (Figs. 5 A & B). As shown in Fig. 5C, progesterone (P4)
alone at a physiological concentration of 10−7 M also induced
CXCR4 in mBMCs. The combination of E2 and P4 resulted in a
similar level of expression as treatment with either sex
steroid alone. Ethanol was used as a vehicle to determine
the non-specific effects on the CXCR4 expression. Ethanol
treated cells does not showed any change in the CXCR4
expression comparing to control cells which are not treated
either by ethanol or E2 or P4. Western blot analysis
confirmed that CXCR4 protein induction was significantly
increased (2.68-fold) after treatment with 10−7 M E2 for
24 h (Fig. 5D) while E2 at a concentration of 10−8 M showed
no induction. Conversely, E2 at a concentration of 10−6 M
did not increase CXCR4 protein levels compared to untreated
cells. In summary, physiological concentrations of E2 and P4
results in increased expression of CXCR4 in mBMCs.Based on the results of steroid-induced CXCR4 expression,
physiological levels (10−7 M) of E2 and P4 were selected for
examination of the effects of sex steroids on CXCL12
production. As shown in Fig. 5E, neither E2 nor P4 had any
effect on CXCL12 production in mBMCs. However, in hESCs,
E2 caused a significant increase in CXCL12 production
compared to control and surprisingly P4 effectively inhibited
E2-induced CXCL12 production in hESCs (Fig. 5F). In the both
cell types mBMC and hESCs the protein levels were
correlated to the mRNA levels confirmed by qRT-PCR.
mBMC migration towards E2 and P4 treated hESC
supernatants
To determine if the enhanced CXCL12 and CXCR4 production
induced by E2 would increase migration of BMCs to hESCs,
we treated hESCs and mBMCs with E2 and performed a
migration assay using the conditioned media, with and
without the CXCR4 antagonist. The hESC supernatants were
collected from 48 h old cultures. The mBMC in the upper
insert were pretreated with 1 × 10−7 M E2 for 24 h after
overnight serum starvation. Migration of mBMC was observed
after 16 h. As shown in Fig. 6, mBMC migrated towards the
E2-induced hESC supernatant in greater numbers compared
to the untreated hESC supernatant. The number of migrated
mBMCs decreased 42–51% when mBMCs were pretreated
with the CXC4 antagonist AMD3100. The E2 induced
migration of BMCs to hESCs was mediated by CXCL12/CXCR4.
Discussion
Bone marrow derived stem cells migrate to the uterine
endometrium of both mice and humans (Du and Taylor,
2007; Taylor, 2004). This migration likely has a key role in
the repair of the uterus after damage. Indeed, our group has
previously demonstrated that migration and engraftment of
BM derived stem cells to the uterine endometrium is
increased after ischemic injury and decreased by environ-
mental toxins such as tobacco (Zhou et al., 2011; Wolff et
al., 2011). Further, BMC delivery to mice after injury
improved reproductive performance (Alawadhi et al., 2014)
and mBMCs express several nuclear receptors (Wang et al.,
2006; Zhou et al., 2001; Jeong and Mangelsdorf, 2009).
Characterization of the chemokines that regulate stem cell
engraftment may allow increased engraftment of endoge-
nous stem cells injury. It has been previously shown in other
tissues that increased CXCL12 production at a site of injury
enhances stem cell recruitment and promotes functional
recovery (Liu et al., 2013b; Penn et al., 2012; Sundararaman
et al., 2011; Unzek et al., 2007). Here we demonstrate that
bone marrow cells will migrate towards endometrial cell
conditioned media; this chemoattraction of CXCR4 express-
ing bone marrow cells is similarly mediated by CXCL12
production by endometrial cells.
CXCL12 has been previously identified as an estrogen-
regulated gene in estrogen receptor (ER)-positive ovarian
and breast cancer cells (Jaerve et al., 2012). Here we show
that in the endometrium, E2 significantly increased CXCL12
expression, suggesting a mechanism by which stem cells are
recruited to the uterus in reproductive age women; it is
likely that this recruitment ceases after menopause when
Figure 3 The detection of CXCR4 and CD45 in mBMCs with fluorescent ICC. Representative photomicrographs of fluorescent ICC for
CD45 (A, green) and CXCR4 (B, red) expression in mBMCs (100×), DAPI-stained nuclei are depicted in blue (C), and merged CD45 and
CXCR4 are shown in (D).
Figure 4 The chemotactic activity of conditioned supernatants
to mBMC and hESCs. The migratory capacity of mBMC towards
hESC supernatant. Untreated or AMD100 treated for 30 min
mBMCs were seeded (5 × 104/well) on the top of inserts and
placed in a 24-well plate containing serum-free medium alone
(control) or 48 h hESC serum-free supernatant. Data are shown as
CI: cells migrating in response to the conditioned supernatants
divided by cells responding to the serum-free medium. Bars
represent the mean ± S.D. of four independent experiments,
each performed in triplicate. * denotes a statistically signifi-
cant difference (p b 0.05) vs control; # (p b 0.05) vs the cells
without AMD3100 treatment.
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an increase in CXCR4 in bone marrow in response to estrogen
enhances the mobility of these cells when needed for
reproduction and in response to uterine signaling. Interest-
ingly BM cells also produce CXCL12 at a high level. It is likely
that local CXCL12 serves to retain these cells in the BM,
preventing depletion. Elevated CXCL12 from the endometrium
likely competes with BM derived CXCL12 as a chemoattractant
for the BM stem cells (Segers et al., 2007). Elevated E2, which
reaches the levels used here in the late proliferative phase,
may ensure an adequate mobilization of stem cells near the
time of ovulation and embryo implantation. P4 also induces
the production of CXCL12 andmay lead to further mobilization
of stem cells in support of pregnancy.
The regulation of stem cells by sex steroids is likely a
widespread phenomenon. Nakada et al. (Nakada et al.,
2014) showed that E2 promotes the HSCs self-renewal and
the replicative activity of the HSC pool is augmented in
female versus male mice. Li et al. (2013) reported that E2
enhanced the recruitment of BM-derived EPC into infarcted
myocardium and induced CXCR4 expression in mice. Simi-
larly, Foresta et al. (2010) have observed an increase in the
number of CXCR4+ EPC during the ovulatory phase, which
was likely caused by E2 activation. Sex steroid induced
alterations in stem cell renewal and mobilization may
underlie many sex specific differences in health and disease.
In the ectopic endometrium of endometriosis, high E2
biosynthesis and low E2 inactivation lead to an excess of
local E2 (Giudice and Kao, 2004). These provide a favorable
condition for inducing BM-derived stem cell migration to
normal and ectopic endometrium. Consistent with this
theory, we have previously shown that stem cells are
A B
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Figure 5 E2 and progesterone (P4) induced CXCR4 and CXCL12 expression in mBMC and hESCs. mBMCs were serum starved
overnight prior to being stimulated with E2 or P4 in fresh serum-free DMEM/F12 medium for 6 h and 24 h and CXCR4 mRNA was
analyzed by qRT-PCR. (A & B) E2-induced CXCR4 mRNA expression at 6 h and 24 h. (C) E2 alone or plus with P4-induced CXCR4 mRNA
expression at 24 h. (D) Western blot analysis of E2-induced CXCR4 protein at 24 h. (E & F) mBMC and hESCs were serum starved
overnight and supernatants were collected for ELISA analysis after the cells were stimulated with E2 or P4 for 48 h in serum-free
DMEM/F12. The bars in each graph represent the mean ± S.D. of three individual experiments, each performed in triplicate.
Statistical significance (*p b 0.05) is noted on the graphs (*p b 0.05 vs control, *p b 0.05 vs E2).
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The ectopic lesions compete for a limited pool of circulating
BM-derived cells, depriving the uterus of the normal number
of recruited stem cells. Insufficient uterine repair and
regeneration may contribute to the infertility associated
with endometriosis. The identification of CXCL12 as theprimary chemokine that recruits BM-derived cells to the
uterus may allow therapeutic use in endometriosis and other
uterine disease to restore fertility. The expression of CXCL12
in mouse endometrial cells is far less than endometrial cells
in humans. This may be the cause for the decrease in the
number of stem cells recruited to the uterus in mouse.
Figure 6 Effects of E2 on migratory capacity of mBMC.
Untreated or E2-treated mBMCs were seeded (5 × 104/well)
on the top of inserts and placed in a 24-well plate containing
serum-free DMEM/F12 or 48 h hESCs serum-free supernatant.
The cells were pretreated with AMD3100 for 30 min before
migration. Data are shown as CI: cells migrating in response to
the conditioned supernatants divided by cells responding to
the serum-free medium. Each bar represents the mean ± S.D.
for data from three individual experiments and each experiment
was performed in triplicate. * denotes statistical significance
(p b 0.05) compared to control, and # denotes statistical signifi-
cance (p b 0.05) compared to U1 or E2.
21Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cellsMoreover, mice do not menstruate and thereby may not be a
need to attract new cells with every cycle while humans
menstruate and have a greater need to regenerate the
endometrium from stem cells. We conclude that estradiol
plays a key role in normal and ectopic endometrium by
augmenting the migration of BM-derived stem cells to the
endometrium. Estradiol regulates stem cell migration by
inducing CXCL12 expression by endometrial stromal cells and
CXCR4 expression by BM-derived cells. Sex steroid induced
stem cell recruitment may explain many health related sex
differences. Estradiol or CXCL12/CXCR4 may prove to be
useful therapeutic agents in stem cell mediated diseases.Acknowledgments
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